Safety and Performance of the Biphasic Plate Distal Femur: a Multicenter Case Series
- Conditions
- Distal Femur FractureSupracondylar FracturePeriprosthetic FracturesIntra-Articular Fractures
- Registration Number
- NCT06028971
- Lead Sponsor
- 41medical AG
- Brief Summary
The goal of this observational multicenter case series is to assess the safety and performance of the CE-marked "Biphasic Plate Distal Femur" during standard of care.
- Detailed Description
The goal of this observational study is to assess the safety and performance of the CE-marked "Biphasic Plate Distal Femur" during standard of care. The study is conducted as a retrospective and prospective multicenter case series. Eligible patients are those with fractures of the distal femur who are treated with the Biphasic Plate DF according to the Instruction for Use (IFU). The patient will be followed-up until healing or up to 12 months, whichever comes first.
To assess the safety and performance following data is collected:
* incidents of AEs/SAEs occurring in the affected lower extremity/extremities
* Bone healing assessed by a surgeon
* Weightbearing and function
* Patients' quality of life and pain level
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 60
-
Patients with fractures of the distal femur requiring internal fixation and treated with the Biphasic Plate DF as indicated according to the IFU. As per the IFU, the Biphasic Plate DF is indicated for:
- Distal shaft fractures
- Supracondylar fractures
- Intraarticular fractures
- Periprosthetic fractures
-
No other major implant beside the Biphasic Plate DF is used for fixation of the distal femur fracture, with the exceptions of lag screw(s) and/or cerclage wire(s), and/or a joint replacement.
-
Patients who are willing and able to comply with postoperative FUs per local standard of care.
-
Ability to provide informed consent according to the IRB/EC defined and approved procedures.
-
Patients over 18 years of age
Exclusion Criteria (preoperatively):
- Patient is participating in another interventional clinical trial.
Exclusion Criteria (intraoperatively):
- Change of surgical plan intraoperatively at the discretion of the surgeon that Biphasic Plate DF is not used
- Necessity to apply a second (medial) plate (double plating) or an intramedullary nail in case of critical fixation distally
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurrence of AEs/SAEs in the affected lower extremity/extremities until clinically healed or up to 12 months The primary outcome measure is the occurrence of AEs/SAEs in the affected lower extremity/extremities that are deemed related, probably related, or possibly related to the surgical procedure or the Biphasic Plate DF
- Secondary Outcome Measures
Name Time Method Bone Healing until clinically healed or up to 12 months Radiographic bone healing assessment using the modified Radiographic Union Scale for Tibia (mRUST) Score (1: Callus absent, visible fracture line, 2: Callus present, visible fracture line, 3: Callus bridging, visible fracture line, 4: Callus remodeled, invisible fracture line)
Bone healing as assessed by the surgeonPatient-reported outcome measures until clinically healed or up to 12 months Quality of life questionaire Pain NRS (0-10) upon weightbearing
Trial Locations
- Locations (5)
Univeritätsklinikum Münster
🇩🇪Münster, Nordrhein-Westfalen, Germany
Diakonie Jung-Stilling Siegen
🇩🇪Siegen, Nordrhein-Westfalen, Germany
Kantonsspital Graubünden
🇨🇭Chur, Graubünden, Switzerland
Universitätsspital Basel
🇨🇭Basel, Switzerland
Universitätsspital Zürich
🇨🇭Zürich, Switzerland